The Epidemiologic Study of Human Cytomegalovirus(CMV) in Female Students of Xiamen University
NCT02642822 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 102
Last updated 2016-07-14
Summary
In this study, 100 female students aged 18 to 30 years old in Xiamen University will be enrolled. On the first visit, blood, saliva and urine samples of all participants will be collected. Then saliva and urine samples will be collected at two-week interval until 6 months. Serum samples will be tested the PP150-IgG titer. Saliva and urine samples will be used to test CMV DNA by PCR. The primary purpose of this study is to identify the relationship between baseline PP150-IgG titer and CMV infection.
Conditions
- Cytomegalovirus Infections
Sponsors & Collaborators
-
Jun Zhang
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 30 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2014-10-31
- Primary Completion
- 2016-04-30
- Completion
- 2016-04-30
Countries
- China
Study Locations
More Related Trials
-
Immune Response to Cytomegalovirus
NCT00034437 ·Status: COMPLETED
-
Subclinical Cytomegalovirus Reactivation in Acute ANCA-associated Vasculitis
NCT04916704 ·Status: ACTIVE_NOT_RECRUITING
-
Safety Study of Human Anti-Cytomegalovirus Monoclonal Antibody
NCT01594437 ·Status: COMPLETED ·Phase: PHASE1
-
Cytomegalovirus Infection in Critically Ill Patients and Patients Receiving Anticancer Therapy
NCT04280380 ·Status: UNKNOWN
-
Cell Mediated Immunity for Secondary Prophylaxis in CMV SOT Patients
NCT02370758 ·Status: COMPLETED ·Phase: NA
-
Congenital CYtoMEgalovirus Infection in VIEtnam (CYMEVIE)
NCT04822142 ·Status: RECRUITING
-
Cytomegalovirus (CMV) Transmission and Immune Tracking (TransmIT) Study
NCT06522880 ·Status: RECRUITING
-
Evaluation of the Pharmacokinetics (PK) and Pharmacodymamics (PD) of Ganciclovir (GCV) in Premature Infants Receiving Treatment for Cytomegalorivus (CMV) Infection
NCT01602614 ·Status: COMPLETED
-
Evaluation of the Safety and Immune Responses of the Towne Strain of CMV in Seronegative Women
NCT00201448 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
A Study of MCMV5322A/MCMV3068A for the Prevention of Cytomegalovirus Disease in High-Risk Kidney Allograft Recipients
NCT01753167 ·Status: COMPLETED ·Phase: PHASE2
-
Prediction of Cytomegalovirus (CMV) Reactivation in Intensive Care Unit (ICU) by Immunological Study
NCT02843880 ·Status: TERMINATED
-
Cytomegalovirus (CMV) MicroRNA Expression in Vivo and Immune Evasion Correlates
NCT00677482 ·Status: COMPLETED
-
A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of Cytomegalovirus (CMV) Vaccine mRNA-1647
NCT05105048 ·Status: COMPLETED ·Phase: PHASE1
-
Cytomegalovirus (CMV) Vaccines: Reinfection and Antigenic Variation
NCT03443791 ·Status: COMPLETED ·Phase: NA
-
Comparison of Two Test Methods-NASBA and Antigenemia-for Detecting Cytomegalovirus Infection
NCT00001976 ·Status: COMPLETED
-
A Study of Safety and Immune Response to Different Doses of a Cytomegalovirus Vaccine in Healthy Adults
NCT05089630 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study on Correlation Between Cytomegalovirus and Ocular Myasthenia Gravis
NCT05091177 ·Status: UNKNOWN
-
Cell-mediated Immunity for Prevention of CMV Disease
NCT02538172 ·Status: COMPLETED ·Phase: NA
-
Safety Study of Four Chimera Cytomegalovirus (CMV) Vaccines in Healthy Adult Males 30-50 Years of Age
NCT01195571 ·Status: COMPLETED ·Phase: PHASE1
-
The Relationship Between CMV* Reactivation and Anti-cytokine Treatment in Critical COVID-19 Patients
NCT05419206 ·Status: COMPLETED
-
Clinical Performance Evaluation of DxN CMV Assay
NCT03127787 ·Status: TERMINATED
-
Assesment of Olfactory Disorders and Performance of a New Olfactory Test in Children With Congenital CMV
NCT02782988 ·Status: COMPLETED
-
Risk Factors for Cytomegalovirus Disease in Solid Organ Transplantation
NCT00170170 ·Status: COMPLETED
-
Cell Mediated Immunity and the Prediction of CMV Infection In Solid Organ Transplant Recipients
NCT00436384 ·Status: COMPLETED
-
Evaluation of CMV/EBV-CMI in Haploid HSCT
NCT06554197 ·Status: RECRUITING